ArticleJournal of general internal medicine2026
Growth and Financial Outcomes of a Remote Physiologic Monitoring Service for Hypertension in the Primary Care Setting.
Article in Journal of general internal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRemote physiologic monitoring (RPM) presents a promising solution for hypertension management through efficient blood pressure monitoring outside of the traditional clinic setting utilizing monitors that transmit readings automatically to the healthcare team. Barriers to adoption of RPM include addressing the challenge of managing continuous streams of data, patient capability, and financial sustainability. The impacts of different RPM models on enrollment and financial outcomes are unknown.
objectiveThe primary objective of this study was to describe the operationalization and expansion of a pharmacist-led RPM service for hypertension in primary care, highlighting its two phases and describing the financial considerations associated with the program.
designRetrospective descriptive study using a data analytics platform, operational logs, and chart review of the electronic health record.
participantsPatients enrolled in the hypertension RPM service from July 1, 2022, to May 21, 2024. MAIN MEASURES: Number of patients enrolled per month, average duration of enrollment for patients in the program, frequency and categorical distribution of RPM codes billed, average charges submitted per patient enrolled, and average reimbursement per patient enrolled. KEY
resultsPhase 1, which took place over 14 months, included 140 patients with average charges submitted of $301.46 per patient and average reimbursement of $96.30. The average enrollment duration was 155 days. Phase 2, which took place over 9 months, included 167 patients, with average charges of $412.93 and average reimbursement of $124.17 per patient. Average enrollment duration was 63 days. The categorical distribution of codes billed differed significantly between the two phases (p-value < 0.001).
conclusionsUsing clinic-owned Bluetooth-enabled BP monitors that were reused kept the costs of the program low but may have limited enrollment. Use of vendor-provided cellular-enabled monitors was more costly but may have facilitated additional billing opportunities and program growth. Pharmacists play a central role in delivering RPM services.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.